Pfizer Hopes New CEO Ian Read Can Help Drugmaker Overcome Lipitor Revenue Loss
{ Posted on Dec 07 2010 by Kerri Shannon }
Pfizer Inc. (NYSE: PFE) surprised analysts and investors Sunday by announcing the replacement of Chief Executive Officer Jeffrey B. Kindler with Ian C. Read, the company's head of global biopharmaceutical operations. The move was made as the ...Read More »
Unique in the industry, Macroaxis financial engineering platform delivers measurable value in the form of improved return on your investment portfolios | 

